Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride

Osteoarthritis and Cartilage

Volumn 16, Issue 9, 2008, Pages 973-979

  Meulyzer, M ^a   Vachon, P ^a   Beaudry, F ^a   Vinardell, T ^a   Richard, H ^a   Beauchamp, G ^a   Laverty, S ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cartilage; Glucosamine; Horse; Neutraceutical; Osteoarthritis

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE SULFATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SYNOVIAL FLUID LEVEL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HORSE; LIQUID CHROMATOGRAPHY; MEAN RESIDENCE TIME; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; TANDEM MASS SPECTROMETRY; WRIST;

ADULT; ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FEMALE; GLUCOSAMINE; HORSES; HUMANS; INJECTIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL; SYNOVIAL FLUID;

EID: 49149092608     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.01.006     Document Type: Article

References (35)

1. Bruyere O., Pavelka K., Rovati L.C., Gatterova J., Giacovelli G., Olejarova M., et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 16 (2008) 254-260
2. Pavelka K., Gatterova J., Olejarova M., Machacek S., Giacovelli G., and Rovati L.C. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162 18 (2002) 2113-2123
3. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 9252 (2001) 251-256
4. Hughes R., and Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford) 41 3 (2002) 279-284
5. Cibere J., Kopec J.A., Thorne A., Singer J., Canvin J., Robinson D.B., et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 51 5 (2004) 738-745
6. Cibere J., Thorne A., Kopec J.A., Singer J., Canvin J., Robinson D.B., et al. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol 32 5 (2005) 896-902
7. Tiraloche G., Girard C., Chouinard L., Sampalis J., Moquin L., Ionescu M., et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum 52 4 (2005) 1118-1128
8. Reginster J.Y., Bruyere O., and Neuprez A. Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 46 5 (2007) 731-735
9. Altman R.D., Abramson S., Bruyere O., Clegg D., Herrero-Beaumont G., Maheu E., et al. Commentary: osteoarthritis of the knee and glucosamine. Osteoarthritis Cartilage 14 10 (2006) 963-966
10. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354 8 (2006) 795-808
11. Herrero-Beaumont G., Ivorra J.A., Del Carmen Trabado M., Blanco F.J., Benito P., Martin-Mola E., et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 56 2 (2007) 555-567
12. Russell A.S., Aghazadeh-Habashi A., and Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 29 11 (2002) 2407-2409
13. Oke S., Aghazadeh-Habashi A., Weese J.S., and Jamali F. Evaluation of glucosamine levels in commercial equine oral supplements for joints. Equine Vet J 38 1 (2006) 93-95
14. Laverty S., Sandy J.D., Celeste C., Vachon P., Marier J.F., and Plaas A.H. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum 52 1 (2005) 181-191
15. Persiani S., Rotini R., Trisolino G., Rovati L.C., Locatelli M., Paganini D., et al. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage 15 7 (2007) 764-772
16. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2 (2005) CD002946
17. Beaudry F., and Vachon P. Determination of glucosamine in horse plasma by liquid chromatography tandem mass spectrometry. Biomed Chromatogr 22 1 (2008) 1-4
18. Bioanalytical method validation. Guidance for Industry (May 2001), Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM). http://www.fda.gov/cder/guidance/4252fnl.pdf
19. Rowland M., and Towser T.N. Clinical Pharmacokinetics: Concepts and Applications (1995), Lippincott Williams and Wilkins, Philadelphia
20. Aghazadeh-Habashi A., Sattari S., Pasutto F., and Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J Pharm Pharm Sci 5 2 (2002) 181-184
21. Adebowale A., Du J., Liang Z., Leslie J.L., and Eddington N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23 6 (2002) 217-225
22. Du J., White N., and Eddington N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse. Biopharm Drug Dispos 25 3 (2004) 109-116
23. Setnikar I., Palumbo R., Canali S., and Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 43 10 (1993) 1109-1113
24. Wang S.X., Laverty S., Dumitriu M., Plaas A., and Grynpas M.D. The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum 56 5 (2007) 1537-1548
25. Persiani S., Roda E., Rovati L.C., Locatelli M., Giacovelli G., and Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage 13 12 (2005) 1041-1049
26. Biggee B.A., Blinn C.M., McAlindon T.E., Nuite M., and Silbert J.E. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis 65 2 (2006) 222-226
27. Levick J.R. Microvascular architecture and exchange in synovial joints. Microcirculation 2 3 (1995) 217-233
28. Moskowitz R.W. Osteoarthritis: Diagnosis And Medical/Surgical Management. 4th edn. (2007), Wolters Kluwer Health/Lippincott Williams and Wilkins, Philadelphia
29. Errecalde J.O., Carmely D., Marino E.L., and Mestorino N. Pharmacokinetics of amoxycillin in normal horses and horses with experimental arthritis. J Vet Pharmacol Ther 24 1 (2001) 1-6
30. Firth E.C., Klein W.R., Nouws J.F., and Wensing T. Effect of induced synovial inflammation on pharmacokinetics and synovial concentration of sodium ampicillin and kanamycin sulfate after systemic administration in ponies. J Vet Pharmacol Ther 11 1 (1988) 56-62
31. Kraus V.B., Huebner J.L., Fink C., King J.B., Brown S., Vail T.P., et al. Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum 46 2 (2002) 420-427
32. Neil K.M., Orth M.W., Coussens P.M., Chan P.S., and Caron J.P. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta. Am J Vet Res 66 11 (2005) 1861-1869
33. Chan P.S., Caron J.P., Rosa G.J., and Orth M.W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 13 5 (2005) 387-394
34. Celeste C., Ionescu M., Robin Poole A., and Laverty S. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 23 3 (2005) 602-610
35. van den Boom R., van de Lest C.H., Bull S., Brama R.A., van Weeren P.R., and Barneveld A. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J 37 3 (2005) 250-256